Trials / Completed
CompletedNCT00802308
Effects of a Single Dose of Egalet® Morphine Combined With a Single Dose of Alcohol in Healthy Moderate Drinkers
A Randomized, Partially Blind, Four-way Crossover Study to Determine the Effects of a Single Dose of Egalet® Morphine Combined With a Single Dose of Alcohol in Healthy Male and Female Moderate Drinkers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Egalet Ltd · Industry
- Sex
- All
- Age
- 19 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to evaluate the pharmacokinetics of Egalet® morphine when administered with alcohol and compare to administration with water.
Detailed description
Outcome: Pharmacokinetic parameters
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Morphine sulphate | Extended release tablet combined with alcohol or water |
Timeline
- Start date
- 2008-12-01
- Primary completion
- 2009-02-01
- Completion
- 2009-02-01
- First posted
- 2008-12-04
- Last updated
- 2016-09-14
Source: ClinicalTrials.gov record NCT00802308. Inclusion in this directory is not an endorsement.